Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.

Archives of medical research - 1 Sept 2025

Espinoza-Zamora Ramiro, Zapata-Canto Nidia Paulina, Aguilera-Urbina Lizbeth Deyanir, Cruz-Velazquez Judith, Reyes-Maldonado Elba, Vela-Ojeda Jorge

Abstract excerpt

BACKGROUND AND AIMS: Multiple myeloma is the second most common hematologic cancer and remains incurable. Several prognostic factors have been identified, but many are costly and inaccessible to most hematology centers. To explore the clinical, laboratory, and cytogenetic factors that influence survival in patients with newly diagnosed multiple myeloma. METHODS: The research included 286 patients treated with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols

Share to L-Lactate Dehydrogenase

Share to Multiple Myeloma

Share to Prognosis

Share to Proteasome Inhibitors

Share to Thalidomide

Source

Identifiers

PMID: 40493976
DOI: 10.1016/j.arcmed.2025.103239

Genes

RB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased LDH Remains a Crucial Prognostic Factor in Patients with Multiple Myeloma.PMID 40493976Read ↗

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read ↗

Current Review on High-Risk Multiple Myeloma.Semantic proximity Read ↗

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases.Semantic proximity Read ↗

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment responseSemantic proximity Read ↗

Haematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-line Treatment With a Bortezomib-based RegimenSemantic proximity Read ↗

Clinical implications of cytogenetic and molecular aberrations in multiple myelomaSemantic proximity Read ↗

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read ↗

Risk Stratification and Targets in Multiple Myeloma: From Genomics to the BedsideSemantic proximity Read ↗

A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy.Semantic proximity Read ↗

Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based RegimenSemantic proximity Read ↗

Extramedullary Disease in Multiple Myeloma.Semantic proximity Read ↗

Multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.